A Multicenter, Randomized, Double-Blind, Phase 3 Study O

Project: Research project

Description

A Multicenter, Randomized, Double-Blind, Phase 3 Study Of Sunitinib Plus Prednisone Versus Prednisone In Patients With Progressive Metastatic Hormone-Refractory Prostate Cancer After Failure of Docetaxel-Based Chemotherapy Regimen
StatusActive
Effective start/end date3/27/0812/31/20

Funding

  • PFIZER, INC.

Fingerprint

docetaxel
Prednisone
Prostatic Neoplasms
Hormones
Drug Therapy
sunitinib